DUBLIN – Dublin-based venture capital firm Fountain Healthcare Partners closed its third fund, Fountain Healthcare Partners Fund III, LP, with a raise of €118 million (US$131.5 million), which it will invest in biotech, specialty pharma and med-tech firms in Europe and, to a lesser extent, the U.S.